STOCK TITAN

ANIP (NASDAQ: ANIP) files Form 144 reporting sale of 6,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ANIP submitted a Form 144 notice reporting a proposed sale of 6,000 common shares through Morgan Stanley Smith Barney LLC. The filing lists restricted stock lots dated 04/27/2023 (1,698 shares), 05/23/2024 (3,865 shares) and 05/21/2025 (437 shares).

Positive

  • None.

Negative

  • None.

Insights

Form 144 notice reports a proposed resale of restricted common stock totaling 6,000 shares.

Form 144 is a regulatory notice enabling a holder to effect a public resale of restricted or control securities in reliance on Rule 144. The filing lists specific restricted stock lots with grant dates and share counts that support the proposed sale.

Practical implications depend on whether the broker clears trades and whether volume/holding-period conditions of Rule 144 are met; timing and proceeds treatment are not stated in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ANIP's Form 144 report?

The filing reports a proposed resale of 6,000 common shares. It lists restricted stock lots dated 04/27/2023 (1,698), 05/23/2024 (3,865) and 05/21/2025 (437).

Who is the broker handling the proposed sale for ANIP?

The broker shown is Morgan Stanley Smith Barney LLC. The filing lists that broker as the executing broker for the proposed sale but does not state timing or execution details.

Are the securities in ANIP's Form 144 restricted or unrestricted?

The filing identifies the listed securities as Restricted Stock. Each lot entry includes a grant date and share count, indicating these are restricted shares subject to resale conditions.

Does the Form 144 state how proceeds will be used?

The excerpt does not state any use-of-proceeds or who will receive sale proceeds. The filing focuses on the quantities, broker, and grant dates for the restricted shares.

When was ANIP's Form 144 filed or dated in the excerpt?

The excerpt includes a date field showing 03/03/2026 near the filer header. Individual restricted-stock grant dates are 04/27/2023, 05/23/2024, and 05/21/2025.
Ani Pharmaceutic

NASDAQ:ANIP

ANIP Rankings

ANIP Latest News

ANIP Latest SEC Filings

ANIP Stock Data

1.71B
19.14M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
BAUDETTE